Scientific Profiles in the field of Biomarkers (2000-2010) by Biglu, Mohammad-Hossein et al.
 International Journal of Information Science and Management 
Vol. 3, No. 2 (Vol. 11, No. 2), 2013, 25-34 
 
 
  
Scientific Profiles in the field of Biomarkers (2000-2010) 
 
Mohammad-Hossein Biglu 
Associate professor, Research Center for 
Pharmaceutical Nanotechnology, Tabriz University 
of Medical Sciences, Tabriz, Iran 
Corresponding author: mh_biglu@yahoo.com 
 
Sahar Biglu 
Asien-Afrika-Institut, Hamburg University, 
Hamburg, Germany 
 
Mehdi Saberian-Brojeni 
Pharmacology and Toxicology Department, Faculty 
of Pharmacy, Tabriz University of Medical Science, 
Tabriz, Iran
 
Giti Shahmohammadi 
Medical Information Science Department, 
Paramedical Faculty, Tabriz University of  
Medical Sciences, Tabriz, Iran 
 
Abstract 
Biological marker is a term used in many scientific fields and was introduced as a 
measurable element or a clinical indicator in the abnormal biological processes, 
pathological condition, or pharmacological intervention. Science Citation Index 
Expanded (SCI-E) from database of Web of Science (WoS) was used to extract all 
publication indexed as a topic of “Biomarkers” during a period of eleven years 
through 2000-2010. Extracting of data was restricted to the tag of topics (TS = 
Biomarkers) from advanced search menu. A total number of 37397 records were 
extracted on 5 May 2013 and went under analysis. In this study the papers 
originated jointly by multiple authors from different countries were defined as ones 
for each country. The study showed that the number of publication in the field of 
biomarkers showed an increase through the period of study. The number of 
publication in 2010 was greater than 10 times in 2000. More than 98% of 
publication was in English. The majority of publication (68%) was in the form 
journal article. Harvard University, sharing 1,128 papers in the field, was the most 
prolific university among institutes. The USA contributing 33% of world’s profile 
in the field was the most productive country. Based on the Bradford’s scattering 
law, the journal of “Cancer Epidemiology Biomarkers Prevention” publishing 
3.12% of world’s publication was the most prolific journal among core journals. 
Analysis of data concluded that oncology was the most interesting subject area of 
scientists in the field of Biomarkers through the last decade. 
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Introduction 
In the early 1960s, American biologist Marshall Nirenberg provided a brilliant experiment 
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in biochemistry that led to a molecular revolution. The revolution in molecular science has 
introduced biomarkers as an important subject in medical science (Goo, 2010). The biomarker 
definition has been changed by new developments in the diagnostic technology over time. 
Perhaps the traditional definition of biomarkers was used only for the proteins which were 
measurable in the body fluids; but the progress in the imaging techniques and other diagnostic 
methods, also has introduced certain conditions such as the structural changes in the human 
body or brain electroencephalography (EEG) as the biomarker of certain diseases (Beveren 
and Hoogendijk, 2011; Garea, Griese, and Imhof., 2007; Goo, 2010). According to the 
biomarkers definitions working group a biomarker is "a characteristic that is objectively 
measured and evaluated as an indicator of normal biological processes, pathogenic processes, 
or pharmacologic responses to a therapeutic intervention" (Biomarkers-Definitions-Working-
Group, 2001). Therefore, the scientific definition of biomarkers was expanded to include not 
only the proteins and their fragments, but also metabolites, carbohydrate biomarkers, and 
genomic biomarkers (RNA and DNA) (Gormally Caboux, Vineis, and Hainaut, 2007; Kraus 
et al., 2011; Suspiro and Prista, 2011). Today, the importance of biomarkers as measurable 
indicators in the normal and pathological processes has led to using these objects in different 
fields of medical sciences, i.e. diagnostic, responses to drug therapy, side effects of therapy, 
and prediction of disease (Kraus et al., 2011; Mayeux, 2004; Suspiro and Prista, 2011; Vainio, 
2001). Since the biomarkers of a disease are detectable even in the first stages of a 
pathological condition, these elements attract a lot of interest in the diagnostic processes of 
specific diseases, in particular, cancer, and the number of publications in this field is growing 
fast (Au, 2007; Cazzola and Novelli, 2010; Cummings, 2011; Eason and Halloran, 2002; 
Ganti and Weiss, 2011; Schaaij-Visser, Brakenhoff, Leemans, Heck, and Slijper, 2010). 
Although the diagnostic processes by the biomarkers are very interesting and useful, two main 
aspects of progress should have been obtained in this area. First, the progress in the analytical 
procedures and accuracy of analytical equipments are an important subject for biomarker 
tracing. Second, the vast researches should be performed to discover specific biomarkers for 
specific conditions (Garea et al., 2007; He and Yu, 2012; Lobdell and Mendola, 2005; 
Mayeux, 2004; Wehrens, Franceschi, Vrhovsek, and Mattivi, 2011). Therefore, the 
publications of a country in this field could be considered as an index for the overall progress 
of that country in this subject (Biglu, 2008). This study investigated all publication indexed 
under the topic of Biomarkers in SCI-E and visualized the scientific activity of leading 
countries in the field through 2000-2010.  
 
Method 
Science Citation Index expanded (SCI-E) from database of web of science was used to extract 
all publication indexed as a topic of “Biomarkers” during a period of eleven years through 
2000-2010. We restricted extracting of data to the tag of topics (TS = Biomarkers) from 
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advanced search menu. This led to retrieving all documents indexed as a topic of Biomarkers 
in SCI-E. A total number of 37397 records on 5 May 2013 were extracted and analyzed. 
Science Citation Index Expanded (SCI-E) is a citation database that covers more than 8000 
journals in JCR Science Edition and more than 2600 journals in JCR Social Sciences, across 
150 disciplines, from 1900 to the present. This database allows researchers to access the 
bibliographic information of publication and to identify which later articles have cited any 
particular earlier article, or cited the articles of any particular author, or determine which 
articles have been cited most frequently. In this study the papers originated jointly by multiple 
authors from different countries were defined as ones for each country. For example if a paper 
had three authors from three different countries, we counted one paper for each of them. 
Regarding to calculating the number of published papers during the period of study each 
paper counted as one regardless to the number of contributor countries/institutions. Therefore, 
the occurrence of countries/institutions is greater than the total number of published papers.  
 
Findings 
Analysis of data obtained from database of Science Citation Index- Expanded (SCI-E) 
throughout a period of eleven years indicated that the number of publication in the field of 
Biomarkers has increased steady through the period of study. (Fig. 1) 
 
 
Figure 1.  Number of publication in the field of Biomarkers in SCI-E 2000-2010 
 
As figure 1 shows, total number of 37397 papers were indexed under topic of Biomarkers 
in SCI-E in the period of 2000-2010. The number of scientific publication in the field of 
Biomarkers increased exponential through the period of under study. It reached from 701 
papers in 2000 to 8603 papers in 2010. 
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Figure 2. Global percentage of publication in the field of Biomarkers contributed by 10 top productive 
countries in SCI-E 2000-2010 
 
Figure 2 shows the 10 top productive countries sharing scientific profiles in the field of 
Biomarkers. As it could be seen, 7% of world’s profile was produced by 10 top productive 
countries. Except Russia all other G8 countries were among 10 top productive countries. 
USA, sharing 33% (16141 papers) of global publication, was the most productive country 
followed by England 7% (3,237 papers), Germany 6% (3,049 papers), Italy 5% (2,298 
papers), France 4% (1,979 papers), Canada 4% (1,970 papers), Spain 3% (1,510 papers), 
Netherlands 3% (1,499 papers) and Japan 3% (1,430 papers), respectively. 
 
 
Figure 3.  Percentage of publication in the field of Biomarkers contributed by G8 countries 2000-2010 
 
The G8 countries altogether contributed 30,249 papers in SCI-E database. This number 
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accounted for 61% of world’s publication in the field in SCI-E. Figure 3 shows the percentage 
share of scientific profiles by each G8 countries in the field of Biomarkers among themselves. 
From a total number of 30,249 papers published by G8 countries, 53% was produced by USA, 
11% by England, 10% by Germany, 8% by Italy, 6% by France, 6% by Canada, 5% by Japan 
and 1% by Russia, respectively. 
 
Table 1 
Frequency of Documents Type for publication in the field of Biomarkers in SCI-E 2000-2010 
Document Types Records Percent 
ARTICLE 27069 68% 
REVIEW 4909 12% 
MEETING ABSTRACT 3854 10% 
PROCEEDINGS PAPER 2368 6% 
EDITORIAL MATERIAL 1047 3% 
LETTER 270 1% 
NEWS ITEM 148 0% 
BOOK CHAPTER 102 0% 
CORRECTION 83 0% 
REPRINT 10 0% 
BIOGRAPHICAL ITEM 4 0% 
SOFTWARE REVIEW 2 0% 
DATABASE REVIEW 1 0% 
Total 39867 100% 
 
Journal articles, consisting 68% of total publications type, was the most dominant format 
of publication followed by Review articles (12%) and Meetings abstract (10%). Some papers 
were published in two or more formats. That is why the number of publication types shown in 
table 1 is greater than the number of retrieved papers from SCI-E shown in figure 1. 
English, consisting 36757 papers (98.3%), was the most frequent language followed by 
French 175 papers (0.5%), German 159 papers (0.4%), and Spanish 122 papers (0.3%).  Some 
papers were found in other languages such as Chinese (46 papers), Portuguese (37 papers), 
polish (24 papers), Russian (23 papers), Japanese (11 papers), Czech (10 papers), Korea (8 
papers), Italian (7 papers), Serbian (6 papers), Turkish (4 papers), Croatian (2 papers), Malay 
(2 papers), Slovenian (2 papers), and one paper in Dutch, Estonian, Lithuanian, and 
Romanian. 
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Table 2 
Top twenty subject areas of publication in the field of Biomarkers in SCI-E 2000-2010 
Rank Research Areas Records Percent 
1 ONCOLOGY 5733 10% 
2 BIOCHEMISTRY MOLECULAR BIOLOGY 4686 8% 
3 TOXICOLOGY 3390 6% 
4 ENVIRONMENTAL SCIENCES ECOLOGY 2790 5% 
5 PUBLIC ENVIRONMENTAL OCCUPATIONAL HEALTH 2461 4% 
6 PHARMACOLOGY PHARMACY 2405 4% 
7 CHEMISTRY 2235 4% 
8 NEUROSCIENCES NEUROLOGY 2225 4% 
9 CARDIOVASCULAR SYSTEM CARDIOLOGY 2181 4% 
10 RESEARCH EXPERIMENTAL MEDICINE 1339 2% 
11 BIOTECHNOLOGY APPLIED MICROBIOLOGY 1305 2% 
12 ENDOCRINOLOGY METABOLISM 1266 2% 
13 NUTRITION DIETETICS 1224 2% 
14 GENERAL INTERNAL MEDICINE 1125 2% 
15 PATHOLOGY 1088 2% 
16 CELL BIOLOGY 1074 2% 
17 GENETICS HEREDITY 1074 2% 
18 UROLOGY NEPHROLOGY 997 2% 
19 MARINE FRESHWATER BIOLOGY 889 2% 
20 MEDICAL LABORATORY TECHNOLOGY 867 2% 
 
Regarding the subject categories, oncology, consisting 10% of world’s publication in the 
field of Biomarkers, was the most dominant subject area of researches related to the 
Biomarkers followed by “Biochemistry  Molecular Biology” (8%), and “Toxicology” (6%) 
(Table 2). 
 
Table 3 
Twenty top core journals publishing papers in the field of Biomarkers in SCI-E 2000-2010 
Rank Source Titles Record Count percentage 
1 CANCER EPIDEMIOLOGY BIOMARKERS 
PREVENTION 
1163 3.12% 
2 JOURNAL OF PROTEOME RESEARCH 409 1.10% 
3 CLINICAL CANCER RESEARCH 380 1.02% 
4 PROTEOMICS 320 0.86% 
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Rank Source Titles Record Count percentage 
5 ORGANIC GEOCHEMISTRY 308 0.83% 
6 BIOMARKERS 234 0.63% 
7 CLINICAL CHEMISTRY 234 0.63% 
8 CIRCULATION 233 0.63% 
9 MOLECULAR CELLULAR PROTEOMICS 224 0.60% 
10 CANCER RESEARCH 223 0.60% 
11 ENVIRONMENTAL HEALTH PERSPECTIVES 216 0.58% 
12 JOURNAL OF CLINICAL ONCOLOGY 215 0.58% 
13 PLOS ONE 214 0.57% 
14 AQUATIC TOXICOLOGY 208 0.56% 
15 PROTEOMICS CLINICAL APPLICATIONS 194 0.52% 
16 ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY 189 0.51% 
17 BIOMARKERS IN MEDICINE 187 0.50% 
18 ANALYTICAL CHEMISTRY 180 0.48% 
19 TOXICOLOGY LETTERS 178 0.48% 
20 JOURNAL OF NUTRITION 176 0.47% 
 
A total number 3186 journal provided papers in the field of Biomarkers through 2000-
2010. Twenty top prolific of them is shown in Table 3. The journal of “Cancer 
EPIDEMIOLOGY Biomarkers Prevention” publishing 1,163 papers was the most prolific 
journal among core journals followed by “Journal of Proteome Research” publishing 409 
papers, “Clinical Cancer Research” 380 papers, and journal of “Proteomics” publishing 320 
papers. 
 
Table 4 
Most productive Institutes distributing papers in the field of Biomarkers in SCI-E 2000-2010 
Rank Institution Records Percent 
1 HARVARD UNIV 1128 1.2% 
2 NCI 764 0.8% 
3 UNIV WASHINGTON 488 0.5% 
4 JOHNS HOPKINS UNIV 465 0.5% 
5 UNIV TORONTO 428 0.5% 
6 BRIGHAM WOMENS HOSP 405 0.4% 
7 UNIV MICHIGAN 405 0.4% 
8 UNIV TEXAS 397 0.4% 
9 UNIV CALIF SAN FRANCISCO 396 0.4% 
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Rank Institution Records Percent 
10 UNIV PENN 394 0.4% 
11 UNIV PITTSBURGH 382 0.4% 
12 DUKE UNIV 368 0.4% 
13 UNIV CALIF LOS ANGELES 368 0.4% 
14 UNIV N CAROLINA 357 0.4% 
15 UNIV MINNESOTA 345 0.4% 
16 MAYO CLIN 331 0.4% 
17 FRED HUTCHINSON CANC RES CTR 324 0.4% 
18 MASSACHUSETTS GEN HOSP 318 0.4% 
19 UNIV CALIF SAN DIEGO 299 0.3% 
20 CHINESE ACAD SCI 292 0.3% 
 
A total number of 18,528 institutes shared their work in SCI-E. Harvard University, 
publishing 1.2% (1,128 papers) of global profiles in the field of Biomarkers, was the most 
prolific Institute followed by NCI sharing 764 papers, and University of Washington sharing 
488 papers. 
  
Discussion and Conclusion 
Analysis of data indicated that the number of scientific publication in the field of 
Biomarkers increased exponential through the period under study. USA, sharing 33% of 
global publication in the field, was the most productive country followed by England (7%), 
Germany (6%), Italy (5%), France (4%), Canada (4%), Spain (3%), Netherlands (3%) and 
Japan (3%), respectively. According to the results, 71% of world’s profile was produced by 
these 10 top productive countries. Except Russia all G8 countries appeared among 10 top 
productive countries. 
The G8 countries altogether contributed 61% of global publications in the field of 
Biomarkers in SCI-E database. From a total number of 30,249 papers published by G8 
countries, 53%  came from USA, 11%  from England, 10% from Germany, 8% from Italy, 
6% from  France, 6% from Canada, 5% from  Japan and  only 1%  came from Russia. English 
consisting 98.3% of total publications language was the most frequent language of 
publications in the field. This phenomoe should not come as a surprise, because the editorial 
policy of languages in this database has focused on indexing papers in English rather than 
other languages (Biglu, 2007).  The majority of publications types (68%) were in the format 
of Journal articles followed by Review articles (12%) and Meetings abstract (10%).  
American authors, accounting for 33% of global publications, were the most productive in the 
field followed by authors from England (7%), Germany (6%) and Italy (5%). This is an 
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expected suggestion, because a large number of institutes engaging with biomarkers are 
located in North America and Western Europe. Regarding the subject categories, Oncology 
consisting 10% of world’s publication in the field of Biomarkers, was the most dominant 
subject area of researches in the field of Biomarkers. This is a hint that this branch of 
medicine has drawn the concern of oncologists to deals with tumors, including study of their 
development, diagnosis, treatment, and prevention. The following subject areas were 
“Biochemistry Molecular Biology” (8%), and “Toxicology” (6%). Based on the Bradford’s 
scattering law the journal of “Cancer Epidemiology Biomarkers Prevention” publishing 1,163 
papers was the most prolific journal among core journals followed by “Journal of Proteome 
Research”, “Clinical Cancer Research”, and “Proteomics”. Among universities and Institutes 
the Harvard University, sharing 1.25% of global profiles in the field of Biomarkers, was the 
most prolific University followed by NCI, and University of Washington. 
 
References 
Au, W. W. (2007). Usefulness of biomarkers in population studies From exposure to 
susceptibility and to prediction of cancer. International Journal of Hygiene and 
environmental Health, 210 (3-4), 239-246.  
Beveren, N. J. and Hoogendijk, W. J. (2011). Clinical Utility of Serum biomarkers for major 
Psychiatric disorders. International Review of Neurobiology, 101, 351-374. 
Biglu, M. H. (2008). Scientometric study of patent literature in MEDLINE and SCI. Doctoral 
dissertation, Humboldt-Universität zu Berlin, Institut für Bibliotheks-und 
Informationswissenschaft. 
Biglu, M. H. (2007). The editorial policy of languages is being changed in MEDLINE. 
ACIMED 16 (3). 
Biomarkers-Definitions-Working-Group. (2001). Biomarkers and surrogate endpoints: 
preferred definitions and conceptual framework. Inernational Journal of Clinical 
Pharmacoogy andl Therapeutics, 69(3), 89-95. 
Cazzola, M., and Novelli, G. (2010). Biomarkers in COPD. Pulm Pharmacol Ther, 23(6), 
493-500.  
Cummings, J. L. (2011). Biomarkers in Alzheimer's disease drug development. Alzheimer's 
and Dementia, 7(3), e13-e44.  
Eason, C. and Halloran, K. O. (2002). Biomarkers in toxicology versus ecological risk 
assessment. Toxicology, 181,182, 517-521. 
Ganti, S. and Weiss, R. H. (2011). Urine metabolomics for kidney cancer detection and 
biomarker discovery. Urol Oncol: Seminars and Original Investigations, 29(5), 551-557. 
Garea, A. V., Griese, M., and Imhof, A. (2007). Biomarker discovery from body fluids using 
mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci, 849(1-2), 105-114. 
Goo, Y. A. (2010). Advances in proteomic prostate cancer biomarker discovery. J Proteome, 
Scientific Profiles in the field of Biomarkers (2000-2010) 
 
IJISM, Vol. 3, No. 2 (Vol. 11, No. 2)                                                                                July / December 2013 
34 
73(10), 1839-1850.  
Gormally, E., Caboux, E., Vineis, P., and Hainaut, P. (2007). Circulating free DNA in plasma 
or serum as biomarker of carcinogenesis Practical aspects and biological significance. 
Mutat Res, 635(2-3), 105-117. 
He, Z., and Yu, W. (2012). Stable feature selection for biomarker discovery. Computational  
Biology and Chemistry, 34(4), 215-225.  
Kraus, V., Burnett, B., Coindreau, J., Cottrell, S., Eyre, D., and Gendreau, M. (2011). 
Application of biomarkers in the development of drugs intended for the treatment of 
osteoarthritis. Osteoarthr Cartilage, 19(4), 215-542. 
Lobdell, D. T. and Mendola, P. (2005). Development of a biomarkers database for the 
National Children's Study. Toxicology and Applied Pharmacology, 206(2), 269-273. 
Mayeux, R. (2004). Biomarkers: Potential Uses and Limitations. NeuroRx, 1(2), 182-188. 
Schaaij-Visser, T. B., Brakenhoff, R. H., Leemans, C. R., Heck, A. J., and Slijper, M. (2010). 
Protein biomarker discovery for head and neck cancer. Journal of Proteome , 73(10), 
1790-1803.  
Suspiro, A., and Prista, J. (2011). Biomarkers of occupational exposure do anticancer agents: 
A minireview. Toxicol Lett, 207(1), 42-52.  
Vainio, H. (2001). Use of biomarkers in risk assessment. International Journal of Hygiene 
and environmental Health, 204(2-3), 91-102.  
Wehrens, R., Franceschi, P., Vrhovsek, U., and Mattivi, F. (2011). Stability-based biomarker 
selection. Analytica Chimica Acta, 705(1-2), 15-23. 
 
